Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
CytoDyn Inc. (CYDY) had Income from Continuous Operations of $-22.61M for the most recently reported fiscal quarter, ending 2025-11-30.
| Income Statement Financials | |
-- |
|
$-22.61M |
|
-- |
|
-- |
|
$21.69M |
|
$-21.69M |
|
$-0.92M |
|
$-22.61M |
|
$-22.61M |
|
$-22.61M |
|
|
Income from Continuous Operations |
$-22.61M |
$-22.61M |
|
$-22.61M |
|
$-21.69M |
|
$-21.68M |
|
1.26B |
|
1.26B |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$8.84M |
|
-- |
|
$0.10M |
|
$8.94M |
|
$85.11M |
|
-- |
|
$43.57M |
|
$128.68M |
|
$-119.75M |
|
$-119.75M |
|
$-119.75M |
|
1.27B |
|
| Cash Flow Statement Financials | |
$-6.80M |
|
-- |
|
$-0.12M |
|
$11.90M |
|
$4.98M |
|
$-6.92M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.10 |
|
-- |
|
-- |
|
-- |
|
-0.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
18.88% |
|
18.88% |
|
-253.02% |
|
18.88% |
|
$-0.09 |
|
$-0.01 |
|
$-0.01 |
|